Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anal cancer: current and future methodology.

Cathy Eng1

  • 1University of Texas MD Anderson Cancer Center, Department of Gastrointestinal Medical Oncology, Houston, TX 77030, USA.

Cancer Investigation
|August 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updates on Management of Anal Cancer: A New Era Has Begun.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

Trends in primary surgery and overall survival in non-metastatic anal cancer: a population-based analysis.

The oncologist·2026
Same author

Amivantamab Monotherapy in Chemorefractory <i>RAS</i>/<i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Trends in primary surgery and overall survival in non-metastatic anal cancer: a population-based analysis.

The oncologist·2026
Same author

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

The Lancet. Oncology·2026
Same author

Unmasking inequalities in gastrointestinal cancer outcomes among Asian American subpopulations.

Scientific reports·2026

Anal canal cancer is challenging to treat. While chemoradiation alone can cure it, combined therapies cause significant side effects. Novel approaches are being explored for this rare cancer.

Area of Science:

  • Oncology
  • Gastroenterology

Background:

  • Carcinoma of the anal canal is a rare but challenging malignancy.
  • Current standard treatment involves chemoradiation, which can lead to significant morbidity.

Purpose of the Study:

  • To review novel treatment approaches for anal canal cancer.
  • To address the challenges in managing this malignancy.

Main Methods:

  • Literature review of current and emerging therapies.
  • Discussion of treatment-related morbidity and novel strategies.

Main Results:

  • Chemoradiation alone offers a potential cure for anal canal cancer.
  • Combined modality therapy can result in substantial treatment-related morbidity.

Related Experiment Videos

Conclusions:

  • Novel therapeutic strategies are under investigation for anal canal cancer.
  • Balancing treatment efficacy with reduced morbidity is a key focus.